This page is part of the Potential Drug-Drug Interaction (PDDI) Clinical Decision Support (CDS) (FHIR IG) (v0.2.0: STU 1 Ballot 2) based on FHIR R4. . For a full list of available versions, see the Directory of published versions
<ValueSet xmlns="http://hl7.org/fhir"> <id value="valueset-nepafenac-exclude"/> <text> <status value="generated"/> <div xmlns="http://www.w3.org/1999/xhtml"><ul><li>Include these codes as defined in <a href="http://www.nlm.nih.gov/research/umls/rxnorm"><code>http://www.nlm.nih.gov/research/umls/rxnorm</code></a> version <code>02-Jul-2018</code><table class="none"><tr><td style="white-space:nowrap"><b>Code</b></td><td><b>Display</b></td></tr><tr><td>603978</td><td>nepafenac 1 MG/ML Ophthalmic Suspension [Nevanac]</td><td/></tr><tr><td>1365866</td><td>nepafenac 3 MG/ML Ophthalmic Suspension [Ilevro]</td><td/></tr><tr><td>603977</td><td>nepafenac Ophthalmic Suspension [Nevanac]</td><td/></tr><tr><td>1365864</td><td>nepafenac Ophthalmic Suspension [Ilevro]</td><td/></tr><tr><td>578044</td><td>nepafenac 1 MG/ML Ophthalmic Suspension</td><td/></tr><tr><td>1362132</td><td>nepafenac 3 MG/ML Ophthalmic Suspension</td><td/></tr><tr><td>578043</td><td>nepafenac Ophthalmic Suspension</td><td/></tr><tr><td>1158407</td><td>nepafenac Ophthalmic Product</td><td/></tr><tr><td>1365865</td><td>Ilevro Ophthalmic Product</td><td/></tr><tr><td>1182860</td><td>Nevanac Ophthalmic Product</td><td/></tr></table></li></ul></div> </text> <url value="http://hl7.org/fhir/uv/pddi/ValueSet/valueset-nepafenac-exclude"/> <version value="0.2.0"/> <name value="Valueset_nepafenac_exclude"/> <title value="Exclude Nepafenac Medications Value Set"/> <status value="draft"/> <date value="2018-07-02"/> <publisher value="PDDI CDS"/> <contact> <name value="Richard Boyce"/> </contact> <description value="ValueSet containing drug identifiers to exclude. Criteria is explicitly stating topical, gel, cream, ointment, otic, or ophthalmic formulations."/> <jurisdiction> <coding> <system value="http://unstats.un.org/unsd/methods/m49/m49.htm"/> <code value="001"/> <display value="World"/> </coding> </jurisdiction> <purpose value="To refine valueset for Warfarin + NSAID PDDI-CDS"/> <copyright value="Attribution CC BY"/> <compose> <include> <system value="http://www.nlm.nih.gov/research/umls/rxnorm"/> <version value="02-Jul-2018"/> <concept> <code value="603978"/> <display value="nepafenac 1 MG/ML Ophthalmic Suspension [Nevanac]"/> </concept> <concept> <code value="1365866"/> <display value="nepafenac 3 MG/ML Ophthalmic Suspension [Ilevro]"/> </concept> <concept> <code value="603977"/> <display value="nepafenac Ophthalmic Suspension [Nevanac]"/> </concept> <concept> <code value="1365864"/> <display value="nepafenac Ophthalmic Suspension [Ilevro]"/> </concept> <concept> <code value="578044"/> <display value="nepafenac 1 MG/ML Ophthalmic Suspension"/> </concept> <concept> <code value="1362132"/> <display value="nepafenac 3 MG/ML Ophthalmic Suspension"/> </concept> <concept> <code value="578043"/> <display value="nepafenac Ophthalmic Suspension"/> </concept> <concept> <code value="1158407"/> <display value="nepafenac Ophthalmic Product"/> </concept> <concept> <code value="1365865"/> <display value="Ilevro Ophthalmic Product"/> </concept> <concept> <code value="1182860"/> <display value="Nevanac Ophthalmic Product"/> </concept> </include> </compose> </ValueSet>